Prevention of Readmissions at IBD Centres of Excellence

Clinical trial NCT02931799 · UNKNOWN

Trial details

NCT number: NCT02931799
Sponsor: Mount Sinai Hospital, Canada
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Colitis, Ulcerative Crohn Disease Inflammatory Bowel Diseases

Start date: 2018-10-01
Primary completion: 2021-09-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.